EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice

Justin T Denholm, Emma S McBryde

Tuberculosis Research and Treatment · 2010

DOI: 10.1155/2010/284028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tuberculosis Research and Treatment, 2010. Verfasst von Justin T Denholm und 1 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Infectious Diseases Service, Royal Melbourne Hospital, Grattan Street, Parkville, VIC, 3050, Australia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Thoracic Society of Australian and New Zealand.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To survey practices in the diagnosis and management of latent tuberculosis infection (LTBI) in Australia and New Zealand.

Methods

Infectious diseases and respiratory physicians and trainees were invited to complete an online questionnaire concerning various aspects of LTBI management.

Results

The questionnaire was completed by 126 clinicians self-reporting regular management of LTBI. Respondents were experienced physicians, with 95/126 (75.4%) having managed LTBI for more than 5 years. Forty-seven (37.3%) reported seeing more than 5 patients per month for assessment of LTBI. Substantial variation among clinicians was reported in relation to a number of common clinical scenarios. For instance, while 52/126 (43.7%) informed patients that the incidence of severe hepatotoxicity related to isoniazid monotherapy was 0.1–0.5%, 21/126 (15.7%) thought it was > 5%. 36/126 (28.6%) clinicians would proceed with TNF- a therapy following an indeterminate screening: interferon- ? assay, while 78/126 (61.9%) would perform further investigations and 12/126 (9.5%) would initiate isoniazid therapy. Follow-up intervals during therapy varied from 1–3 monthly, with liver function testing performed routinely by 89/126 (70.6%).

Conclusion

This study demonstrated a large degree of variation in clinical practice of LTBI management in Australia and New Zealand. Strategies for increasing uniformity of practice are required, including improved guidelines and physician education.

Autor:innen und Institutionen

  • Victorian Infectious Diseases Service, Royal Melbourne Hospital, Grattan Street, Parkville, VIC, 3050, Australia.

Förderung

  • Thoracic Society of Australian and New Zealand

Zitieren

APA

Denholm, J. T., & McBryde, E. S. (2010). Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice. Tuberculosis Research and Treatment. https://doi.org/10.1155/2010/284028

Vancouver

Denholm JT, McBryde ES. Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice. Tuberculosis Research and Treatment. 2010. doi:10.1155/2010/284028

BibTeX
@article{Denholm2010,
  author = {Denholm, Justin T and McBryde, Emma S},
  title = {Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice},
  journal = {Tuberculosis Research and Treatment},
  year = {2010},
  doi = {10.1155/2010/284028}
}
Kostenlos starten →